Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis

Heart Rhythm

Volumn 4, Issue 10, 2007, Pages 1292-1299

  Banba, Kimikazu ^a   Kusano, Kengo Fukushima ^a   Nakamura, Kazufumi ^a   Morita, Hiroshi ^a   Ogawa, Aiko ^a   Ohtsuka, Fuyo ^a   Ohta Ogo, Keiko ^a   Nishii, Nobuhiro ^a   Watanabe, Atsuyuki ^a   Nagase, Satoshi ^a   Sakuragi, Satoru ^a   Ohe, Tohru ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cardiac sarcoidosis; Corticosteroid; Gallium scintigraphy; Heart block; Ventricular tachycardia

Indexed keywords

CORTICOSTEROID; GALLIUM CITRATE GA 67; PYROPHOSPHATE TECHNETIUM TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARRHYTHMOGENESIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR CONDUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE BIOPSY; HEART SCINTISCANNING; HEART VENTRICLE TACHYCARDIA; HEART VENTRICULOGRAPHY; HOLTER MONITORING; HOSPITAL ADMISSION; HUMAN; MALE; PRIORITY JOURNAL; SARCOIDOSIS; SYMPTOM; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; AGED; ATRIOVENTRICULAR NODE; BIOPSY; CARDIOMYOPATHIES; CITRATES; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; ENDOCARDIUM; FEMALE; GALLIUM; HEART BLOCK; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDYL-DIPEPTIDASE A; RADIONUCLIDE IMAGING; SARCOIDOSIS; TACHYCARDIA, VENTRICULAR;

EID: 34648816528     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.06.006     Document Type: Article

References (31)

1. Iwai K., Sekiguti M., Hosoda Y., DeRemee R.A., Tazelaar H.D., Sharma O.P., Maheshwari A., and Noguchi T.I. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11 (1994) 26-31
2. Gideon N.M., and Mannino D.M. Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. Am J Med 100 (1996) 423-427
3. Perry A., and Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 119 (1995) 167-172
4. Silverman K.J., Hutchins G.M., and Bulkley B.H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58 (1978) 1204-1211
5. Matsui Y., Iwai K., Tachibana T., Fruie T., Shigematsu N., Izumi T., Homma A.H., Mikami R., Hongo O., Hiraga Y., and Yamamoto M. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 278 (1976) 455-469
6. Roberts W.C., McAllister Jr. H.A., and Ferrans V.J. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 63 (1977) 86-108
7. Shammas R.L., and Movahed A. Sarcoidosis of the heart. Clin Cardiol 16 (1993) 462-472
8. Sharma O.P., Maheshwari A., and Thaker K. Myocardial sarcoidosis. Chest 103 (1993) 253-258
9. Winters S.L., Cohen M., Greenberg S., Stein B., Curwin J., Pe E., and Gomes J.A. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 18 (1991) 937-943
10. Abeler V. Sarcoidosis of the cardiac conducting system. Am Heart J 97 (1979) 701-707
11. Hirose Y., Ishida Y., Hayashida K., Maeno M., Takamiya M., Ohmori F., Miyatake K., Uehara T., Nishimura T., and Tachibana T. Myocardial involvement in patients with sarcoidosis. An analysis of 75 patients. Clin Nucl Med 19 (1994) 522-526
12. Niden A.H., Mishkin F.S., and Khurana M.M. 67Gallium citrate lung scans in interstitial lung disease. Chest 69 2 Suppl (1976) 266-268
13. Line B.R., Hunninghake G.W., Keogh B.A., Jones A.E., Johnston G.S., and Crystal R.G. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am Rev Respir Dis 123 4 Pt 1 (1981) 440-446
14. Okayama K., Kurata C., Tawarahara K., Wakabayashi Y., Chida K., and Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 107 (1995) 330-334
15. Hiraga H.Y.K., and Hiroe M. Guideline for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary disease from the Japanese Ministry of Health and Welfare 6 (1993) 23-24 (in Japanese)
16. Hiramitsu S., Morimoto S., Uemura A., Kato Y., Kimura K., Ohtsuki M., Kato S., Sugiura A., Miyagishima K., Hishida H., Sugisaki K., and Tsuda T. National survey on status of steroid therapy for cardiac sarcoidosis in Japan. Sarcoidosis Vasc Diffuse Lung Dis 22 (2005) 210-213
17. Lown B., and Wolf M. Approaches to sudden death from coronary heart disease. Circulation 44 (1971) 130-142
18. Hunninghake G.W., Costabel U., Ando M., Baughman R., Cordier J.F., du Bois R., Eklund A., Kitaichi M., Lynch J., Rizzato G., Rose C., Selroos O., Semenzato G., and Sharma O.P. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16 (1999) 149-173
19. Costabel U., Bois R.D., and Eklund A. Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. Eur Respir J 7 (1994) 624-627
20. Semenzato G. Assessment of disease activity in sarcoidosis: deeds and misdeeds. Sarcoidosis 10 (1993) 100-103
21. Alavi A., and Palevsky H.I. Gallium67-citrate scanning in the assessment of disease activity in sarcoidosis. J Nucl Med 33 (1992) 751-755
22. Kurata C., Sakata K., Taguchi T., Fukumoto Y., Miyata H., Aoshima S., and Yamazaki N. SPECT imaging with Tl-201 and Ga-67 in myocardial sarcoidosis. Clin Nucl Med 15 (1990) 408-411
23. Haraki T., Ueda K., Shintani H., Hayashi T., Taki J., and Mabuchi H. Spontaneous development of left ventricular aneurysm in a patient with untreated cardiac sarcoidosis. Circ J 66 (2002) 519-521
24. Koplan B.A., Soejima K., Baughman K., Epstein L.M., and Stevenson W.G. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 3 (2006) 924-929
25. Chinushi M., Mezaki T., Aoki Y., Nakagawa I., Washizuka T., and Aizawa Y. Demonstration of transient entrainment in monomorphic sustained ventricular tachycardia associated with cardiac sarcoidosis. Jpn Circ J 64 (2000) 635-637
26. Mezaki T., Chinushi M., Washizuka T., Furushima H., Chinushi Y., Ebe K., Okumura H., and Aizawa Y. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis. Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. Intern Med 40 (2001) 731-735
27. Yazaki Y., Isobe M., Hiroe M., Morimoto S., Hiramitsu S., Nakano T., Izumi T., and Sekiguchi M. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88 (2001) 1006-1010
28. Takeda N., Yokoyama I., Hiroi Y., Sakata M., Harada T., Nakamura F., Murakawa Y., and Nagai R. Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis. Circulation 105 (2002) 1144-1145
29. Lash R., Coker J., and Wong B.Y. Treatment of heart block due to sarcoid heart disease. J Electrocardiol 12 (1979) 325-329
30. Friedman H.S., Parikh N.K., Chander N., and Calderon J. Sarcoidosis with incomplete bilateral bundle branch block pattern disappearing following steroid therapy: an electrophysiological study. Eur J Cardiol 4 (1976) 141-150
31. Kato Y., Morimoto S., Uemura A., Hiramitsu S., Ito T., and Hishida H. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis 20 (2003) 133-137